Skip to main content

View full-text article in PMC

. 2019 Nov 20;43(1):31–40. doi: 10.3892/or.2019.7413

Table I.

Correlation analysis between FTH1P3 expression and clinicopathological index in cervical cancer patients.

		FTH1P3			miR-145

Parameters	n	Low (n)	High (n)	P-value	Low (n)	High (n)	P-value
Age (years)
<50	24	10	14	0.101	11	13	0.525
≥50	28	16	12		15	13
Menopause
Yes	22	10	12	0.438	12	10	0.438
No	30	16	14		14	16
Tumor size (cm)
<4	18	12	6	0.014^a	7	11	0.035^a
≥4	34	14	20		19	15
Depth of invasion
<2/3	21	12	9	0.085	11	10	0.621
≥2/3	31	14	17		15	16
LNM stage
Negative	35	21	14	0.005^b	15	20	0.011^a
Positive	17	5	12		11	6
FIGO stage
I–II	27	20	7	0.002^b	17	10	0.017^a
III–IV	25	6	19		9	16
CEA
Negative	33	18	15	0.083	16	17	0.662
Positive	19	8	11		10	9

^a

P<0.05

^b

P<0.01. FTH1P3, ferritin heavy chain 1 pseudogene 3.